CBit Series Digital Color Doppler Ultrasound System

• K Number: K180974
• Device Name: CBit Series Digital Color Doppler Ultrasound System
• Manufacturer: CHISON Medical Technologies Co., Ltd.
• Date Cleared: 2018-08-17 ( 126 days)
• Product Code: IYN , ITX , IYO
• Regulation Number: 892.1550
• Type: Traditional
• Panel: Radiology
• Reference & Predicate Devices: K150861 , K170374
• Predicate For: K200780

Intended Use

The device is a general-purpose ultrasonic imstrument intended for use by a qualified clinician for evaluation of Fetal , Abdominal, Pediatric, Small Organ (breast, thyroid,testes ), Neonatal Cephalic, Cardiac (adult , pediatric),Musculo-skeletal (Conventional , Superficial) ,Peripheral Vascular,Trans-esophageal,Trans-rectal, Trans-vaginal, OB/GYN and Urology.

Device Description

The CBit Series Digital Color Doppler Ultrasound System is an integrated preprogrammed color doppler ultrasound imaging system, capable of producing high detail resolution intended for clinical diagnostic imaging applications. This system is a Track 3 device that employs a wide array of probes that include linear array, convex array and phased array . This system consists of a mobile console with keyboard control panel, power supply module, color LCD monitor and optional probes. This system is a mobile, general purpose, software controlled, color diagnostic ultrasound system. Its basic function is to acquire ultrasound echo data and to display the image B-Mode (including Fusion Harmonic Imaging). M-Mode, Pulsed (PW) Doppler Mode, Continuous (CW) Doppler Mode, Color Doppler Mode, Power Doppler Mode, Directional Power Doppler Mode, TDI Mode or a combination of these modes, Elastography, 3D/4D.

AI/ML Overview

The provided text is a 510(k) Summary for the CHISON CBit Series Digital Color Doppler Ultrasound System. It describes the device, its intended use, non-clinical tests conducted, and a comparison to predicate devices to establish substantial equivalence. However, it does not contain a study that proves the device meets specific acceptance criteria in terms of quantitative performance metrics for AI algorithms. Instead, the document focuses on regulatory compliance and substantial equivalence to previously cleared devices.

Therefore, many of the requested details about acceptance criteria, their proof, and study specifics for AI performance cannot be extracted from this document as it does not describe such a study.

Here's a breakdown of what can be extracted:

1. A table of acceptance criteria and the reported device performance

The document does not provide a table of acceptance criteria with reported device performance in terms of AI algorithm accuracy, sensitivity, specificity, or other quantitative metrics. The "acceptance criteria" presented are primarily regulatory compliance standards and substantial equivalence to predicate devices, rather than performance benchmarks for AI features.

2. Sample sized used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

Not applicable. The document explicitly states: "No clinical testing was required." Therefore, there is no test set for AI performance, sample size, or data provenance mentioned.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

Not applicable, as no clinical testing and no test set with ground truth establishment for AI performance is described.

4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

Not applicable, as no clinical testing and no test set with ground truth establishment for AI performance is described.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

Not applicable. No MRMC study involving AI assistance is mentioned.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

Not applicable. The document does not describe a standalone AI algorithm performance study. The device is a diagnostic ultrasound system with several operating modes and features, some of which are likely enhanced by AI (features like "Auto IMT," "Auto NT," "Stress Echo," "Strain," "Q-Image," "Q-flow," "Q-beam," "AIO," and "LV tracking" hint at AI analysis or automation), but no specific standalone performance metrics for these AI components are provided.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

Not applicable, as no clinical testing with ground truth establishment for AI performance is described.

8. The sample size for the training set

Not applicable. The document does not describe the development or training of any AI algorithms, therefore no training set sample size is provided.

9. How the ground truth for the training set was established

Not applicable, as no training set or its ground truth establishment is mentioned.

---

Summary of Device Features and Non-Clinical Tests (as presented in the document):

The CHISON CBit Series Digital Color Doppler Ultrasound System is a general-purpose ultrasonic imaging instrument. It is noted to include features like "Elastography," "3D/4D," "TDI Mode," "Auto IMT," "Stress Echo," "Strain," "Q-Image," "Q-flow," "Q-beam," "AIO," and "LV tracking," which often imply some level of algorithmic or AI-assisted processing.

The study presented focuses on non-clinical tests to ensure safety and performance equivalence to predicate devices. These tests evaluated:

• Electrical safety (according to IEC 60601-1: 2005)
• Electromagnetic compatibility (according to IEC 60601-1-2: 2014)
• Basic safety and essential performance of ultrasonic medical diagnostic equipment (according to IEC 60601-2-37: 2007)
• Acoustic output measurements (according to NEMA UD 2:2004)
• Real-time display of thermal and mechanical acoustic output indices (according to NEMA UD3: 2004)
• Biocompatibility (according to ISO 10993-1:2009, ISO 10993-5, ISO 10993-10)
• Software Documentation for a Moderate Level of Concern.

The document states that "The device has been found to conform to applicable medical device safety standards in regards to thermal, mechanical and electrical safety as well as biocompatibility."

The "Substantially Equivalent Conclusion" is reached based on:

• Favorable comparison of Indications for Use with predicate devices.
• Similar operation modes and controls (with some differences in value range, or additional features like LV tracking, LGC, Breast measurement package, which are deemed not to raise new safety or effectiveness concerns as they align with existing functionalities or general measurement packages of predicate devices).
• Compliance with the same safety standards as predicate devices.

The document does not detail any performance studies that would typically involve specific acceptance criteria for AI algorithm performance or metrics derived from clinical data. The focus is on regulatory equivalence concerning the device's overall functionality and safety, not on specific AI performance evaluation against ground truth data.

Summary

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo in blue, with the words "U.S. FOOD & DRUG" above the word "ADMINISTRATION".

CHISON Medical Technologies Co., Ltd. August 17, 2018 % Mr. Liu Qifei Regulatory Affairs Manager No.228, Changjiang East Road, Block 51 and 53, Phase 5, Shuofang Industrial Park Xinwu District, Wuxi, Jiangsu 214142 CHINA

Re: K180974

Trade/Device Name: CBit Series Digital Color Doppler Ultrasound System Regulation Number: 21 CFR 892.1550 Regulation Name: Ultrasonic pulsed doppler imaging system Regulatory Class: II Product Code: IYN, IYO, ITX Dated: July 5, 2018 Received: July 9, 2018

Dear Mr. Qifei:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part

{1}------------------------------------------------

801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm597488.htm); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice

(https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email ([e-mail]) or phone [phone] or 301-796-7100).

Sincerely,

Jeff Bollyer

for Robert Ochs, Ph.D. Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known)

K180974

Device Name

CBit Series Digital Color Doppler Ultrasound System

Indications for Use (Describe)

The device is a general-purpose ultrasonic imstrument intended for use by a qualified clinician for evaluation of Fetal , Abdominal, Pediatric, Small Organ (breast, thyroid,testes ), Neonatal Cephalic, Cardiac (adult , pediatric),Musculo-skeletal (Conventional , Superficial) ,Peripheral Vascular,Trans-esophageal,Trans-rectal, Trans-vaginal, OB/GYN and Urology.

Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)	Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the
time to review instructions, search existing data sources, gather and maintain the data needed and complete
and review the collection of information. Send comments regarding this burden estimate or any other aspect
of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services

Food and Drug Administration

Office of Chief Information Officer

Paperwork Reduction Act (PRA) Staff

[e-mail]

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

Form Approved: OMB No. 0910-0120 Expiration Date: January 31, 2017 See PRA Statement below.

{3}------------------------------------------------

Diagnostic Ultrasound Indications For Use

System: CBit Series Digital Color Doppler Ultrasound System

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical Application	Mode of Operation
General(Track 1 Only)	Specific(Tracks 1 & 3)	B	M	PWDoppler	CWDoppler	ColorDoppler	PowerDoppler	CombinedModes	Other
Ophthalmic	Ophthalmic
Fetal Imaging &Other	Fetal	N	N	N		N	N	N	3,4,6,7
	Abdominal	N	N	N		N	N	N	3,5,6,7
	Intra-operative (Specify)
	Intra-operative (Neuro)
	Laparoscopic
	Pediatric	N	N	N		N	N	N	3,5,6,7
	Small Organ[1] (Specify)	N	N	N		N	N	N	3,5,6,7
	Neonatal Cephalic	N	N	N	N	N	N	N	3,6,7,8
	Adult Cephalic	N	N	N	N	N	N	N	3,6,7,8
	Trans-rectal	N	N	N		N	N	N	3,5,6,7
	Trans-vaginal	N	N	N		N	N	N	3,4,5,6,7
	Trans-urethral
	Trans-esoph. (non-Card.)
	Musculo-skeletal(Conventional)	N	N	N		N	N	N	3,5,6,7
	Musculo-skeletal(Superficial)	N	N	N		N	N	N	3,5,6,7
	Other (OB/GYN)	N	N	N		N	N	N	3,5,6,7
	Other (Urology)	N	N	N		N	N	N	3,5,6,7
Cardiac	Cardiac Adult	N	N	N	N	N	N	N	3,6,7,8
	Cardiac Pediatric	N	N	N	N	N	N	N	3,6,7,8
	Transesophageal	N	N	N	N	N	N	N	3,7,8
Peripheral Vessel	Peripheral vessel	N	N	N		N	N	N	3,5,6,7

P = previously cleared bv FDA: E = added under this appendix N = new indication:

Note : 1. Combined modes are B/M, B/CFM , B/PD, B/PW or CW, B/Color M, B/BC,B/CFM/PW or CW,B/PD or DPD/PW or CW

2. Small Organ: thyroid, testes, breast

3.3D

4.4D

5. Elastography

6. Includes guidance of biopsy (2D)

7. Fusion Harmonic Imaging

8.TDI

Prescription Use メ AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

{4}------------------------------------------------

CBit Series Digital Color Doppler Ultrasound System System: Transducer: D3C60L

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical Application	Mode of Operation
General(Track 1 Only)	Specific(Tracks 1 & 3)	B	M	PWDoppler	CWDoppler	ColorDoppler	PowerDoppler	CombinedModes	Other
Ophthalmic	Ophthalmic
Fetal Imaging &Other	Fetal	N	N	N	N	N	N	N	3,6,7
	Abdominal	N	N	N	N	N	N	N	3,5,6,7
	Intra-operative (Specify)
	Intra-operative (Neuro)
	Laparoscopic
	Pediatric
	Small Organ[1] (Specify)
	Neonatal Cephalic
	Adult Cephalic
	Trans-rectal
	Trans-vaginal
	Trans-urethral
	Trans-esoph. (non-Card.)
	Musculo-skeletal(Conventional)	N	N	N	N	N	N	N	3,5,6,7
	Musculo-skeletal(Superficial)
	Other (OB/GYN)	N	N	N	N	N	N	N	3,5,6,7
	Other (Urology)	N	N	N	N	N	N	N	3,5,6,7
Cardiac	Cardiac Adult
	Cardiac Pediatric
	Transesophageal
Peripheral Vessel	Peripheral vessel	N	N	N	N	N	N	N	3,5,6,7

N = new indication; P = previously cleared by FDA; E = added under this appendix

Note : 1. Combined modes are B/M, B/CFM , B/PD, B/PW or CW, B/Color M, B/BC,B/CFM/PW or CW,B/PD or DPD/PW or CW

2. Small Organ: thyroid, testes, breast

3.3D

4.4D

5. Elastography

6. Includes guidance of biopsy (2D)

7. Fusion Harmonic Imaging

8.TDI

Prescription Use メ AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

{5}------------------------------------------------

CBit Series Digital Color Doppler Ultrasound System System: Transducer: D5C40L

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical Application	Mode of Operation
General(Track 1 Only)	Specific(Tracks 1 & 3)	B	M	PWDoppler	CWDoppler	ColorDoppler	PowerDoppler	CombinedModes	Other
Ophthalmic	Ophthalmic
Fetal Imaging &Other	Fetal	N	N	N		N	N	N	3,6,7
	Abdominal	N	N	N		N	N	N	3,5,6,7
	Intra-operative (Specify)
	Intra-operative (Neuro)
	Laparoscopic
	Pediatric	N	N	N		N	N	N	3,5,6,7
	Small Organ[1] (Specify)
	Neonatal Cephalic
	Adult Cephalic
	Trans-rectal
	Trans-vaginal
	Trans-urethral
	Trans-esoph. (non-Card.)
	Musculo-skeletal(Conventional)	N	N	N		N	N	N	3,5,6,7
	Musculo-skeletal(Superficial)
	Other (OB/GYN)	N	N	N		N	N	N	3,5,6,7
	Other (Urology)	N	N	N		N	N	N	3,5,6,7
Cardiac	Cardiac Adult
	Cardiac Pediatric
	Transesophageal
Peripheral Vessel	Peripheral vessel	N	N	N		N	N	N	3,5,6,7

N = new indication; P = previously cleared by FDA; E = added under this appendix

Note : 1. Combined modes are B/M, B/CFM , B/PD, B/PW or CW, B/Color M, B/BC,B/CFM/PW or CW,B/PD or DPD/PW or CW

2. Small Organ: thyroid, testes, breast

3.3D

4.4D

5. Elastography

6. Includes guidance of biopsy (2D)

7. Fusion Harmonic Imaging

8.TDI

Prescription Use メ AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

{6}------------------------------------------------

CBit Series Digital Color Doppler Ultrasound System System: Transducer: D3C50L

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical Application	Mode of Operation
General(Track 1 Only)	Specific(Tracks 1 & 3)	B	M	PWDoppler	CWDoppler	ColorDoppler	PowerDoppler	CombinedModes	Other
Ophthalmic	Ophthalmic
Fetal Imaging &Other	Fetal	N	N	N	N	N	N	N	3,6,7
	Abdominal	N	N	N	N	N	N	N	3,5,6,7
	Intra-operative (Specify)
	Intra-operative (Neuro)
	Laparoscopic
	Pediatric
	Small Organ[1] (Specify)
	Neonatal Cephalic
	Adult Cephalic
	Trans-rectal
	Trans-vaginal
	Trans-urethral
	Trans-esoph. (non-Card.)
	Musculo-skeletal(Conventional)	N	N	N	N	N	N	N	3,5,6,7
	Musculo-skeletal(Superficial)
	Other (OB/GYN)	N	N	N	N	N	N	N	3,5,6,7
	Other (Urology)	N	N	N	N	N	N	N	3,5,6,7
Cardiac	Cardiac Adult
	Cardiac Pediatric
	Transesophageal
Peripheral Vessel	Peripheral vessel	N	N	N	N	N	N	N	3,5,6,7

N = new indication; P = previously cleared by FDA; E = added under this appendix

Note : 1. Combined modes are B/M, B/CFM , B/PD, B/PW or CW, B/Color M, B/BC,B/CFM/PW or CW,B/PD or DPD/PW or CW

2. Small Organ: thyroid, testes, breast

3.3D

4.4D

5. Elastography

6. Includes guidance of biopsy (2D)

7. Fusion Harmonic Imaging

8.TDI

Prescription Use メ AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

{7}------------------------------------------------

CBit Series Digital Color Doppler Ultrasound System System: Transducer: M3C60L

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical Application	Mode of Operation
General(Track 1 Only)	Specific(Tracks 1 & 3)	B	M	PWDoppler	CWDoppler	ColorDoppler	PowerDoppler	CombinedModes	Other
Ophthalmic	Ophthalmic
Fetal Imaging &Other	Fetal	N	N	N	N	N	N	N	3,6,7
	Abdominal	N	N	N	N	N	N	N	3,5,6,7
	Intra-operative (Specify)
	Intra-operative (Neuro)
	Laparoscopic
	Pediatric
	Small Organ[1] (Specify)
	Neonatal Cephalic
	Adult Cephalic
	Trans-rectal
	Trans-vaginal
	Trans-urethral
	Trans-esoph. (non-Card.)
	Musculo-skeletal(Conventional)	N	N	N	N	N	N	N	3,5,6,7
	Musculo-skeletal(Superficial)
	Other (OB/GYN)	N	N	N	N	N	N	N	3,5,6,7
	Other (Urology)	N	N	N	N	N	N	N	3,5,6,7
Cardiac	Cardiac Adult
	Cardiac Pediatric
	Transesophageal
Peripheral Vessel	Peripheral vessel	N	N	N	N	N	N	N	3,5,6,7

N = new indication; P = previously cleared by FDA; E = added under this appendix

Note : 1. Combined modes are B/M, B/CFM , B/PD, B/PW or CW, B/Color M, B/BC,B/CFM/PW or CW,B/PD or DPD/PW or CW

2. Small Organ: thyroid, testes, breast

3.3D

4.4D

5. Elastography

6. Includes guidance of biopsy (2D)

7. Fusion Harmonic Imaging

8.TDI

Prescription Use メ AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

{8}------------------------------------------------

CBit Series Digital Color Doppler Ultrasound System System: Transducer: H3C60L

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical Application		Mode of Operation							Other
General(Track 1 Only)	Specific(Tracks 1 & 3)	B	M	PWDoppler	CWDoppler	ColorDoppler	PowerDoppler	CombinedModes
Ophthalmic	Ophthalmic
Fetal Imaging &Other	Fetal	N	N	N		N	N	N	3,6,7
	Abdominal	N	N	N		N	N	N	3,5,6,7
	Intra-operative (Specify)
	Intra-operative (Neuro)
	Laparoscopic
	Pediatric
	Small Organ[1] (Specify)
	Neonatal Cephalic
	Adult Cephalic
	Trans-rectal
	Trans-vaginal
	Trans-urethral
	Trans-esoph. (non-Card.)
	Musculo-skeletal(Conventional)	N	N	N		N	N	N	3,5,6,7
	Musculo-skeletal(Superficial)
	Other (OB/GYN)	N	N	N		N	N	N	3,5,6,7
	Other (Urology)	N	N	N		N	N	N	3,5,6,7
Cardiac	Cardiac Adult
	Cardiac Pediatric
	Transesophageal
Peripheral Vessel	Peripheral vessel	N	N	N		N	N	N	3,5,6,7

N = new indication; P = previously cleared by FDA; E = added under this appendix

Note : 1. Combined modes are B/M, B/CFM , B/PD, B/PW or CW, B/Color M, B/BC,B/CFM/PW or CW,B/PD or DPD/PW or CW

2. Small Organ: thyroid, testes, breast

3.3D

4.4D

5. Elastography

6. Includes guidance of biopsy (2D)

7. Fusion Harmonic Imaging

8.TDI

Prescription Use メ AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

{9}------------------------------------------------

CBit Series Digital Color Doppler Ultrasound System System: Transducer: D7L40L

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical Application			Mode of Operation
General(Track 1 Only)	Specific(Tracks 1 & 3)	B	M	PWDoppler	CWDoppler	ColorDoppler	PowerDoppler	CombinedModes	Other
Ophthalmic	Ophthalmic
Fetal Imaging &Other	Fetal
	Abdominal	N	N	N		N	N	N	3,5,6,7
	Intra-operative (Specify)
	Intra-operative (Neuro)
	Laparoscopic
	Pediatric	N	N	N		N	N	N	3,5,6,7
	Small Organ[1] (Specify)	N	N	N		N	N	N	3,5,6,7
	Neonatal Cephalic	N	N	N		N	N	N	3,6,7
	Adult Cephalic
	Trans-rectal
	Trans-vaginal
	Trans-urethral
	Trans-esoph. (non-Card.)
	Musculo-skeletal(Conventional)	N	N	N		N	N	N	3,5,6,7
	Musculo-skeletal(Superficial)	N	N	N		N	N	N	3,5,6,7
	Other (OB/GYN)
	Other (Urology)
Cardiac	Cardiac Adult
	Cardiac Pediatric
	Transesophageal
Peripheral Vessel	Peripheral vessel	N	N	N		N	N	N	3,5,6,7

N = new indication; P = previously cleared by FDA; E = added under this appendix

Note : 1. Combined modes are B/M, B/CFM , B/PD, B/PW or CW, B/Color M, B/BC,B/CFM/PW or CW,B/PD or DPD/PW or CW

2. Small Organ: thyroid, testes, breast

3.3D

4.4D

5. Elastography

6. Includes guidance of biopsy (2D)

7. Fusion Harmonic Imaging

8.TDI

Prescription Use × Over-The-Counter Use AND/OR (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

{10}------------------------------------------------

System: CBit Series Digital Color Doppler Ultrasound System Transducer: D12L40L

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical Application			Mode of Operation								Other
General(Track 1 Only)	Specific(Tracks 1 & 3)	B	M	PWDoppler	CWDoppler	ColorDoppler	PowerDoppler	CombinedModes		Other
Ophthalmic	Ophthalmic
Fetal Imaging &Other	Fetal
	Abdominal	N	N	N	N	N	N	N		3,5,6,7
	Intra-operative (Specify)
	Intra-operative (Neuro)
	Laparoscopic
	Pediatric	N	N	N	N	N	N	N		3,5,6,7
	Small Organ[1] (Specify)	N	N	N	N	N	N	N		3,5,6,7
	Neonatal Cephalic	N	N	N	N	N	N	N		3,6,7
	Adult Cephalic
	Trans-rectal
	Trans-vaginal
	Trans-urethral
	Trans-esoph. (non-Card.)
	Musculo-skeletal(Conventional)	N	N	N	N	N	N	N		3,5,6,7
	Musculo-skeletal(Superficial)	N	N	N	N	N	N	N		3,5,6,7
	Other (OB/GYN)
	Other (Urology)
Cardiac	Cardiac Adult
	Cardiac Pediatric
	Transesophageal
Peripheral Vessel	Peripheral vessel	N	N	N	N	N	N	N		3, 5, 6, 7

N = new indication; P = previously cleared by FDA; E = added under this appendix

Note : 1. Combined modes are B/M, B/CFM , B/PD, B/PW or CW, B/Color M, B/BC,B/CFM/PW or CW,B/PD or DPD/PW or CW

2. Small Organ: thyroid, testes, breast

3.3D

4.4D

5. Elastography

6. Includes guidance of biopsy (2D)

7. Fusion Harmonic Imaging

8.TDI

Prescription Use × AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

{11}------------------------------------------------

System: CBit Series Digital Color Doppler Ultrasound System Transducer: M8L40L

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical Application	Mode of Operation
General(Track 1 Only)	Specific(Tracks 1 & 3)	B	M	PWDoppler	CWDoppler	ColorDoppler	PowerDoppler	CombinedModes	Other
Ophthalmic	Ophthalmic
Fetal Imaging &Other	Fetal
	Abdominal	N	N	N	N	N	N	N	3,5,6,7
	Intra-operative (Specify)
	Intra-operative (Neuro)
	Laparoscopic
	Pediatric	N	N	N	N	N	N	N	3,5,6,7
	Small Organ[1] (Specify)	N	N	N	N	N	N	N	3,5,6,7
	Neonatal Cephalic	N	N	N	N	N	N	N	3,6,7
	Adult Cephalic
	Trans-rectal
	Trans-vaginal
	Trans-urethral
	Trans-esoph. (non-Card.)
	Musculo-skeletal(Conventional)	N	N	N	N	N	N	N	3,5,6,7
	Musculo-skeletal(Superficial)	N	N	N	N	N	N	N	3,5,6,7
	Other (OB/GYN)
	Other (Urology)
Cardiac	Cardiac Adult
	Cardiac Pediatric
	Transesophageal
Peripheral Vessel	Peripheral vessel	N	N	N	N	N	N	N	3,5,6,7

N = new indication; P = previously cleared by FDA; E = added under this appendix

Note : 1. Combined modes are B/M, B/CFM , B/PD, B/PW or CW, B/Color M, B/BC,B/CFM/PW or CW,B/PD or DPD/PW or CW

2. Small Organ: thyroid, testes, breast

3.3D

4.4D

5. Elastography

6. Includes guidance of biopsy (2D)

7. Fusion Harmonic Imaging

8.TDI

Prescription Use × AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

{12}------------------------------------------------

CBit Series Digital Color Doppler Ultrasound System System: Transducer: M8L60L

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical Application			Mode of Operation
General(Track 1 Only)	Specific(Tracks 1 & 3)	B	M	PWDoppler	CWDoppler	ColorDoppler	PowerDoppler	CombinedModes	Other
Ophthalmic	Ophthalmic
Fetal Imaging &Other	Fetal
	Abdominal	N	N	N	N	N	N	N	3,5,6,7
	Intra-operative (Specify)
	Intra-operative (Neuro)
	Laparoscopic
	Pediatric	N	N	N	N	N	N	N	3,5,6,7
	Small Organ[1] (Specify)	N	N	N	N	N	N	N	3,5,6,7
	Neonatal Cephalic	N	N	N	N	N	N	N	3,6,7
	Adult Cephalic
	Trans-rectal
	Trans-vaginal
	Trans-urethral
	Trans-esoph. (non-Card.)
	Musculo-skeletal(Conventional)	N	N	N	N	N	N	N	3,5,6,7
	Musculo-skeletal(Superficial)	N	N	N	N	N	N	N	3,5,6,7
	Other (OB/GYN)
	Other (Urology)
Cardiac	Cardiac Adult
	Cardiac Pediatric
	Transesophageal
Peripheral Vessel	Peripheral vessel	N	N	N	N	N	N	N	3,5,6,7

N = new indication; P = previously cleared by FDA; E = added under this appendix

Note : 1. Combined modes are B/M, B/CFM , B/PD, B/PW or CW, B/Color M, B/BC,B/CFM/PW or CW,B/PD or DPD/PW or CW

2. Small Organ: thyroid, testes, breast

3.3D

4.4D

5. Elastography

6. Includes guidance of biopsy (2D)

7. Fusion Harmonic Imaging

8.TDI

Prescription Use × Over-The-Counter Use AND/OR (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

{13}------------------------------------------------

CBit Series Digital Color Doppler Ultrasound System System: Transducer: D10L30L

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical Application			Mode of Operation						Other
General(Track 1 Only)	Specific(Tracks 1 & 3)	B	M	PWDoppler	CWDoppler	ColorDoppler	PowerDoppler	CombinedModes
Ophthalmic	Ophthalmic
Fetal Imaging &Other	Fetal
	Abdominal
	Intra-operative (Specify)
	Intra-operative (Neuro)
	Laparoscopic
	Pediatric	N	N	N	N	N	N	N	3,5,6,7
	Small Organ[1] (Specify)	N	N	N	N	N	N	N	3,5,6,7
	Neonatal Cephalic
	Adult Cephalic
	Trans-rectal
	Trans-vaginal
	Trans-urethral
	Trans-esoph. (non-Card.)
	Musculo-skeletal(Conventional)	N	N	N	N	N	N	N	3,5,6,7
	Musculo-skeletal(Superficial)	N	N	N	N	N	N	N	3,5,6,7
	Other (OB/GYN)
	Other (Urology)
Cardiac	Cardiac Adult
	Cardiac Pediatric
	Transesophageal
Peripheral Vessel	Peripheral vessel	N	N	N	N	N	N	N	3,5,6,7

N = new indication; P = previously cleared by FDA; E = added under this appendix

Note : 1. Combined modes are B/M, B/CFM , B/PD, B/PW or CW, B/Color M, B/BC,B/CFM/PW or CW,B/PD or DPD/PW or CW

2. Small Organ: thyroid, testes, breast

3.3D

4.4D

5. Elastography

6. Includes guidance of biopsy (2D)

7. Fusion Harmonic Imaging

8.TDI

Prescription Use × Over-The-Counter Use AND/OR (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

{14}------------------------------------------------

CBit Series Digital Color Doppler Ultrasound System System: Transducer: D8L50L

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical Application			Mode of Operation
General(Track 1 Only)	Specific(Tracks 1 & 3)	B	M	PW Doppler	CW Doppler	Color Doppler	Power Doppler	CombinedModes	Other
Ophthalmic	Ophthalmic
Fetal Imaging &Other	Fetal
	Abdominal	N	N	N		N	N	N	3,5,6,7
	Intra-operative (Specify)
	Intra-operative (Neuro)
	Laparoscopic
	Pediatric	N	N	N		N	N	N	3,5,6,7
	Small Organ1 (Specify)	N	N	N		N	N	N	3,5,6,7
	Neonatal Cephalic	N	N	N		N	N	N	3,6,7
	Adult Cephalic
	Trans-rectal
	Trans-vaginal
	Trans-urethral
	Trans-esoph. (non-Card.)
	Musculo-skeletal(Conventional)	N	N	N		N	N	N	3,5,6,7
	Musculo-skeletal(Superficial)	N	N	N		N	N	N	3,5,6,7
	Other (OB/GYN)
	Other (Urology)
Cardiac	Cardiac Adult
	Cardiac Pediatric
	Transesophageal
Peripheral Vessel	Peripheral vessel	N	N	N		N	N	N	3,5,6,7

N = new indication; P = previously cleared by FDA; E = added under this appendix

Note : 1. Combined modes are B/M, B/CFM , B/PD, B/PW or CW, B/Color M, B/BC,B/CFM/PW or CW,B/PD or DPD/PW or CW

2. Small Organ: thyroid, testes, breast

3.3D

4.4D

5. Elastography

6. Includes guidance of biopsy (2D)

7. Fusion Harmonic Imaging

8.TDI

Prescription Use × Over-The-Counter Use AND/OR (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

{15}------------------------------------------------

CBit Series Digital Color Doppler Ultrasound System System: Transducer: D7L40L-REC

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical Application	Mode of Operation
General(Track 1 Only)	Specific(Tracks 1 & 3)	B	M	PWDoppler	CWDoppler	ColorDoppler	PowerDoppler	CombinedModes	Other
Ophthalmic	Ophthalmic
Fetal Imaging &Other	Fetal
	Abdominal
	Intra-operative (Specify)
	Intra-operative (Neuro)
	Laparoscopic
	Pediatric
	Small Organ[1] (Specify)
	Neonatal Cephalic
	Adult Cephalic
	Trans-rectal	N	N	N		N	N	N	3,5,6,7
	Trans-vaginal
	Trans-urethral
	Trans-esoph. (non-Card.)
	Musculo-skeletal(Conventional)
	Musculo-skeletal(Superficial)
	Other (OB/GYN)
	Other (Urology)	N	N	N		N	N	N	3,5,6,7
Cardiac	Cardiac Adult
	Cardiac Pediatric
	Transesophageal
Peripheral Vessel	Peripheral vessel

N = new indication; P = previously cleared by FDA; E = added under this appendix

Note : 1. Combined modes are B/M, B/CFM , B/PD, B/PW or CW, B/Color M, B/BC,B/CFM/PW or CW,B/PD or DPD/PW or CW

2. Small Organ: thyroid, testes, breast

3.3D

4.4D

5. Elastography

6. Includes guidance of biopsy (2D)

7. Fusion Harmonic Imaging

8.TDI

Prescription Use × Over-The-Counter Use AND/OR (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

{16}------------------------------------------------

System: CBit Series Digital Color Doppler Ultrasound System Transducer: V6C10L

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical Application		Mode of Operation							Other
General(Track 1 Only)	Specific(Tracks 1 & 3)	B	M	PWDoppler	CWDoppler	ColorDoppler	PowerDoppler	CombinedModes
Ophthalmic	Ophthalmic
Fetal Imaging &Other	Fetal
	Abdominal
	Intra-operative (Specify)
	Intra-operative (Neuro)
	Laparoscopic
	Pediatric
	Small Organ[1] (Specify)
	Neonatal Cephalic
	Adult Cephalic
	Trans-rectal	N	N	N		N	N	N	3,5,6,7
	Trans-vaginal	N	N	N		N	N	N	3,4,5,6,7
	Trans-urethral
	Trans-esoph. (non-Card.)
	Musculo-skeletal(Conventional)
	Musculo-skeletal(Superficial)
	Other (OB/GYN)	N	N	N		N	N	N	3,5,6,7
	Other (Urology)	N	N	N		N	N	N	3,5,6,7
Cardiac	Cardiac Adult
	Cardiac Pediatric
	Transesophageal
Peripheral Vessel	Peripheral vessel

N = new indication; P = previously cleared by FDA; E = added under this appendix

Note : 1. Combined modes are B/M, B/CFM , B/PD, B/PW or CW, B/Color M, B/BC,B/CFM/PW or CW,B/PD or DPD/PW or CW

2. Small Organ: thyroid, testes, breast

3.3D

4.4D

5. Elastography

6. Includes guidance of biopsy (2D)

7. Fusion Harmonic Imaging

8.TDI

Prescription Use メ AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

{17}------------------------------------------------

System: CBit Series Digital Color Doppler Ultrasound System Transducer: D6C12L

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical Application			Mode of Operation
General(Track 1 Only)	Specific(Tracks 1 & 3)	B	M	PWDoppler	CWDoppler	ColorDoppler	PowerDoppler	CombinedModes	Other
Ophthalmic	Ophthalmic
Fetal Imaging &Other	Fetal
	Abdominal
	Intra-operative (Specify)
	Intra-operative (Neuro)
	Laparoscopic
	Pediatric
	Small Organ1 (Specify)
	Neonatal Cephalic
	Adult Cephalic
	Trans-rectal
	Trans-vaginal	N	N	N		N	N	N	3,5,6,7
	Trans-urethral
	Trans-esoph. (non-Card.)
	Musculo-skeletal
	(Conventional)
	Musculo-skeletal(Superficial)
	Other (OB/GYN)	N	N	N		N	N	N	3,5,6,7
	Other (Urology)	N	N	N		N	N	N	3,5,6,7
Cardiac	Cardiac Adult
	Cardiac Pediatric
	Transesophageal
Peripheral Vessel	Peripheral vessel

P = previously cleared by FDA; N = new indication; E = added under this appendix

Note : 1. Combined modes are B/M, B/CFM , B/PD, B/PW or CW, B/Color M, B/BC,B/CFM/PW or CW,B/PD or DPD/PW or CW

2. Small Organ: thyroid, testes, breast

3.3D

4.4D

5. Elastography

6. Includes guidance of biopsy (2D)

7. Fusion Harmonic Imaging

8.TDI

Prescription Use × AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

{18}------------------------------------------------

System: CBit Series Digital Color Doppler Ultrasound System Transducer: D6C10L

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical Application			Mode of Operation
General(Track 1 Only)	Specific(Tracks 1 & 3)	B	M	PWDoppler	CWDoppler	ColorDoppler	PowerDoppler	CombinedModes	Other
Ophthalmic	Ophthalmic
Fetal Imaging &Other	Fetal
	Abdominal
	Intra-operative (Specify)
	Intra-operative (Neuro)
	Laparoscopic
	Pediatric
	Small Organ[1] (Specify)
	Neonatal Cephalic
	Adult Cephalic
	Trans-rectal	N	N	N	N	N	N	N	3,5,6,7
	Trans-vaginal	N	N	N	N	N	N	N	3,5,6,7
	Trans-urethral
	Trans-esoph. (non-Card.)
	Musculo-skeletal(Conventional)
	Musculo-skeletal(Superficial)
	Other (OB/GYN)	N	N	N	N	N	N	N	3,5,6,7
	Other (Urology)	N	N	N	N	N	N	N	3,5,6,7
Cardiac	Cardiac Adult
	Cardiac Pediatric
	Transesophageal
Peripheral Vessel	Peripheral vessel

P = previously cleared by FDA; N = new indication; E = added under this appendix

Note : 1. Combined modes are B/M, B/CFM , B/PD, B/PW or CW, B/Color M, B/BC,B/CFM/PW or CW,B/PD or DPD/PW or CW

2. Small Organ: thyroid, testes, breast

3.3D

4.4D

5. Elastography

6. Includes guidance of biopsy (2D)

7. Fusion Harmonic Imaging

8.TDI

Prescription Use × AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

{19}------------------------------------------------

System: CBit Series Digital Color Doppler Ultrasound System Transducer: D7C10W

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical Application			Mode of Operation
General(Track 1 Only)	Specific(Tracks 1 & 3)	B	M	PWDoppler	CWDoppler	ColorDoppler	PowerDoppler	CombinedModes	Other
Ophthalmic	Ophthalmic
Fetal Imaging &Other	Fetal
	Abdominal
	Intra-operative (Specify)
	Intra-operative (Neuro)
	Laparoscopic
	Pediatric
	Small Organ[1] (Specify)
	Neonatal Cephalic
	Adult Cephalic
	Trans-rectal	N	N	N	N	N	N	N	3,5,6,7
	Trans-vaginal	N	N	N	N	N	N	N	3,5,6,7
	Trans-urethral
	Trans-esoph. (non-Card.)
	Musculo-skeletal(Conventional)
	Musculo-skeletal(Superficial)
	Other (OB/GYN)	N	N	N	N	N	N	N	3,5,6,7
	Other (Urology)	N	N	N	N	N	N	N	3,5,6,7
Cardiac	Cardiac Adult
	Cardiac Pediatric
	Transesophageal
Peripheral Vessel	Peripheral vessel

N = new indication; P = previously cleared by FDA; E = added under this appendix

Note : 1. Combined modes are B/M, B/CFM , B/PD, B/PW or CW, B/Color M, B/BC,B/CFM/PW or CW,B/PD or DPD/PW or CW

2. Small Organ: thyroid, testes, breast

3.3D

4.4D

5. Elastography

6. Includes guidance of biopsy (2D)

7. Fusion Harmonic Imaging

8.TDI

Prescription Use AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

{20}------------------------------------------------

System: CBit Series Digital Color Doppler Ultrasound System Transducer: D7C10L

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical Application			Mode of Operation
General(Track 1 Only)	Specific(Tracks 1 & 3)	B	M	PWDoppler	CWDoppler	ColorDoppler	PowerDoppler	CombinedModes	Other
Ophthalmic	Ophthalmic
Fetal Imaging &Other	Fetal
	Abdominal
	Intra-operative (Specify)
	Intra-operative (Neuro)
	Laparoscopic
	Pediatric
	Small Organ[1] (Specify)
	Neonatal Cephalic
	Adult Cephalic
	Trans-rectal	N	N	N	N	N	N	N	3,5,6,7
	Trans-vaginal	N	N	N	N	N	N	N	3,5,6,7
	Trans-urethral
	Trans-esoph. (non-Card.)
	Musculo-skeletal(Conventional)
	Musculo-skeletal(Superficial)
	Other (OB/GYN)	N	N	N	N	N	N	N	3,5,6,7
	Other (Urology)	N	N	N	N	N	N	N	3,5,6,7
Cardiac	Cardiac Adult
	Cardiac Pediatric
	Transesophageal
Peripheral Vessel	Peripheral vessel

P = previously cleared by FDA; N = new indication; E = added under this appendix

Note : 1. Combined modes are B/M, B/CFM , B/PD, B/PW or CW, B/Color M, B/BC,B/CFM/PW or CW,B/PD or DPD/PW or CW

2. Small Organ: thyroid, testes, breast

3.3D

4.4D

5. Elastography

6. Includes guidance of biopsy (2D)

7. Fusion Harmonic Imaging

8.TDI

Prescription Use × AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

{21}------------------------------------------------

System: CBit Series Digital Color Doppler Ultrasound System Transducer: M7C10L

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical Application			Mode of Operation							Other
General(Track 1 Only)	Specific(Tracks 1 & 3)	B	M	PWDoppler	CWDoppler	ColorDoppler	PowerDoppler	CombinedModes
Ophthalmic	Ophthalmic
Fetal Imaging &Other	Fetal
	Abdominal
	Intra-operative (Specify)
	Intra-operative (Neuro)
	Laparoscopic
	Pediatric
	Small Organ[1] (Specify)
	Neonatal Cephalic
	Adult Cephalic
	Trans-rectal	N	N	N	N	N	N	N	3,5,6,7
	Trans-vaginal	N	N	N	N	N	N	N	3,5,6,7
	Trans-urethral
	Trans-esoph. (non-Card.)
	Musculo-skeletal(Conventional)
	Musculo-skeletal(Superficial)
	Other (OB/GYN)	N	N	N		N	N	N	3,5,6,7
	Other (Urology)	N	N	N		N	N	N	3,5,6,7
Cardiac	Cardiac Adult
	Cardiac Pediatric
	Transesophageal
Peripheral Vessel	Peripheral vessel

P = previously cleared by FDA; N = new indication; E = added under this appendix

Note : 1. Combined modes are B/M, B/CFM , B/PD, B/PW or CW, B/Color M, B/BC,B/CFM/PW or CW,B/PD or DPD/PW or CW

2. Small Organ: thyroid, testes, breast

3.3D

4.4D

5. Elastography

6. Includes guidance of biopsy (2D)

7. Fusion Harmonic Imaging

8.TDI

Prescription Use × AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

{22}------------------------------------------------

System: CBit Series Digital Color Doppler Ultrasound System Transducer: D7BC8

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical Application	Mode of Operation
General(Track 1 Only)	Specific(Tracks 1 & 3)	B	M	PWDoppler	CWDoppler	ColorDoppler	PowerDoppler	CombinedModes	Other
Ophthalmic	Ophthalmic
Fetal Imaging &Other	Fetal
	Abdominal
	Intra-operative (Specify)
	Intra-operative (Neuro)
	Laparoscopic
	Pediatric
	Small Organ[1] (Specify)
	Neonatal Cephalic
	Adult Cephalic
	Trans-rectal	N	N	N	N	N	N	N	3,5,6,7
	Trans-vaginal	N	N	N	N	N	N	N	3,5,6,7
	Trans-urethral
	Trans-esoph. (non-Card.)
	Musculo-skeletal(Conventional)
	Musculo-skeletal(Superficial)
	Other (OB/GYN)	N	N	N	N	N	N	N	3,5,6,7
	Other (Urology)	N	N	N	N	N	N	N	3,5,6,7
Cardiac	Cardiac Adult
	Cardiac Pediatric
	Transesophageal
Peripheral Vessel	Peripheral vessel

P = previously cleared by FDA; N = new indication; E = added under this appendix

Note : 1. Combined modes are B/M, B/CFM , B/PD, B/PW or CW, B/Color M, B/BC,B/CFM/PW or CW,B/PD or DPD/PW or CW

2. Small Organ: thyroid, testes, breast

3.3D

4.4D

5. Elastography

6. Includes guidance of biopsy (2D)

7. Fusion Harmonic Imaging

8.TDI

Prescription Use × AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

{23}------------------------------------------------

System: CBit Series Digital Color Doppler Ultrasound System Transducer: D3C20L

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical Application	Mode of Operation
General(Track 1 Only)	Specific(Tracks 1 & 3)	B	M	PWDoppler	CWDoppler	ColorDoppler	PowerDoppler	CombinedModes	Other
Ophthalmic	Ophthalmic
Fetal Imaging &Other	Fetal	N	N	N		N	N	N	3,6,7
	Abdominal	N	N	N		N	N	N	3,5,6,7
	Intra-operative (Specify)
	Intra-operative (Neuro)
	Laparoscopic
	Pediatric	N	N	N		N	N	N	3,5,6,7,8
	Small Organ[1] (Specify)
	Neonatal Cephalic
	Adult Cephalic
	Trans-rectal
	Trans-vaginal
	Trans-urethral
	Trans-esoph. (non-Card.)
	Musculo-skeletal(Conventional)	N	N	N		N	N	N	3,5,6,7
	Musculo-skeletal(Superficial)
	Other (OB/GYN)	N	N	N		N	N	N	3,5,6,7
	Other (Urology)	N	N	N		N	N	N	3,5,6,7
Cardiac	Cardiac Adult	N	N	N		N	N	N	3,6,7,8
	Cardiac Pediatric	N	N	N		N	N	N	3,6,7,8
	Transesophageal
Peripheral Vessel	Peripheral vessel	N	N	N		N	N	N	3,5,6,7

N = new indication; P = previously cleared by FDA; E = added under this appendix

Note : 1. Combined modes are B/M, B/CFM , B/PD, B/PW or CW, B/Color M, B/BC,B/CFM/PW or CW,B/PD or DPD/PW or CW

2. Small Organ: thyroid, testes, breast

3.3D

4.4D

5. Elastography

6. Includes guidance of biopsy (2D)

7. Fusion Harmonic Imaging

8.TDI

Prescription Use × AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

{24}------------------------------------------------

CBit Series Digital Color Doppler Ultrasound System System: Transducer: D6C15L

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical Application	Mode of Operation
General(Track 1 Only)	Specific(Tracks 1 & 3)	B	M	PWDoppler	CWDoppler	ColorDoppler	PowerDoppler	CombinedModes	Other
Ophthalmic	Ophthalmic
Fetal Imaging &Other	Fetal	N	N	N	N	N	N	N	3,5,6,7
	Abdominal	N	N	N	N	N	N	N	3,5,6,7
	Intra-operative (Specify)
	Intra-operative (Neuro)
	Laparoscopic
	Pediatric	N	N	N	N	N	N	N	3,5,6,7,8
	Small Organ1 (Specify)
	Neonatal Cephalic	N	N	N	N	N	N	N	3,6,7
	Adult Cephalic
	Trans-rectal
	Trans-vaginal
	Trans-urethral
	Trans-esoph. (non-Card.)
	Musculo-skeletal(Conventional)
	Musculo-skeletal(Superficial)
	Other (OB/GYN)
	Other (Urology)	N	N	N	N	N	N	N	3,5,6,7
Cardiac	Cardiac Adult
	Cardiac Pediatric	N	N	N	N	N	N	N	3,6,7,8
	Transesophageal
Peripheral Vessel	Peripheral vessel

N = new indication; P = previously cleared by FDA; E = added under this appendix

Note : 1. Combined modes are B/M, B/CFM , B/PD, B/PW or CW, B/Color M, B/BC,B/CFM/PW or CW,B/PD or DPD/PW or CW

2. Small Organ: thyroid, testes, breast

3.3D

4.4D

5. Elastography

6. Includes guidance of biopsy (2D)

7. Fusion Harmonic Imaging

8.TDI

Prescription Use × Over-The-Counter Use AND/OR (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

{25}------------------------------------------------

System: CBit Series Digital Color Doppler Ultrasound System Transducer: D5C20L

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical Application	Mode of Operation
General(Track 1 Only)	Specific(Tracks 1 & 3)	B	M	PWDoppler	CWDoppler	ColorDoppler	PowerDoppler	CombinedModes	Other
Ophthalmic	Ophthalmic
Fetal Imaging &Other	Fetal	N	N	N	N	N	N	N	3,5,6,7
	Abdominal	N	N	N	N	N	N	N	3,5,6,7
	Intra-operative (Specify)
	Intra-operative (Neuro)
	Laparoscopic
	Pediatric	N	N	N	N	N	N	N	3,5,6,7,8
	Small Organ1 (Specify)
	Neonatal Cephalic	N	N	N	N	N	N	N	3,6,7
	Adult Cephalic
	Trans-rectal
	Trans-vaginal
	Trans-urethral
	Trans-esoph. (non-Card.)
	Musculo-skeletal(Conventional)
	Musculo-skeletal(Superficial)
	Other (OB/GYN)
	Other (Urology)	N	N	N	N	N	N	N	3,5,6,7
Cardiac	Cardiac Adult	N	N	N	N	N	N	N	3,6,7,8
	Cardiac Pediatric	N	N	N	N	N	N	N	3,6,7,8
	Transesophageal
Peripheral Vessel	Peripheral vessel

N = new indication; P = previously cleared by FDA; E = added under this appendix

Note : 1. Combined modes are B/M, B/CFM , B/PD, B/PW or CW, B/Color M, B/BC,B/CFM/PW or CW,B/PD or DPD/PW or CW

2. Small Organ: thyroid, testes, breast

3.3D

4.4D

5. Elastography

6. Includes guidance of biopsy (2D)

7. Fusion Harmonic Imaging

8.TDI

Prescription Use × AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

{26}------------------------------------------------

CBit Series Digital Color Doppler Ultrasound System System: Transducer: D3P64L

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical Application			Mode of Operation
General(Track 1 Only)	Specific(Tracks 1 & 3)	B	M	PWDoppler	CWDoppler	ColorDoppler	PowerDoppler	CombinedModes	Other
Ophthalmic	Ophthalmic
Fetal Imaging &Other	Fetal
	Abdominal	N	N	N	N	N	N	N	3,6,7
	Intra-operative (Specify)
	Intra-operative (Neuro)
	Laparoscopic
	Pediatric
	Small Organ[1] (Specify)
	Neonatal Cephalic	N	N	N	N	N	N	N	3,6,7,8
	Adult Cephalic	N	N	N	N	N	N	N	3,6,7,8
	Trans-rectal
	Trans-vaginal
	Trans-urethral
	Trans-esoph. (non-Card.)
	Musculo-skeletal(Conventional)
	Musculo-skeletal(Superficial)
	Other (OB/GYN)
	Other (Urology)
Cardiac	Cardiac Adult	N	N	N	N	N	N	N	3,6,7,8
	Cardiac Pediatric	N	N	N	N	N	N	N	3,6,7,8
	Transesophageal
Peripheral Vessel	Peripheral vessel

N = new indication; P = previously cleared by FDA; E = added under this appendix

Note : 1. Combined modes are B/M, B/CFM , B/PD, B/PW or CW, B/Color M, B/BC,B/CFM/PW or CW,B/PD or DPD/PW or CW

2. Small Organ: thyroid, testes, breast

3.3D

4.4D

5. Elastography

6. Includes guidance of biopsy (2D)

7. Fusion Harmonic Imaging

8.TDI

Prescription Use × Over-The-Counter Use AND/OR (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

{27}------------------------------------------------

System: CBit Series Digital Color Doppler Ultrasound System Transducer: D3P64LS

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical Application			Mode of Operation							Other
General(Track 1 Only)	Specific(Tracks 1 & 3)	B	M	PWDoppler	CWDoppler	ColorDoppler	PowerDoppler	CombinedModes
Ophthalmic	Ophthalmic
Fetal Imaging &Other	Fetal
	Abdominal	N	N	N	N	N	N	N	3,6,7
	Intra-operative (Specify)
	Intra-operative (Neuro)
	Laparoscopic
	Pediatric
	Small Organ[1] (Specify)
	Neonatal Cephalic	N	N	N	N	N	N	N	3,6,7,8
	Adult Cephalic	N	N	N	N	N	N	N	3,6,7,8
	Trans-rectal
	Trans-vaginal
	Trans-urethral
	Trans-esoph. (non-Card.)
	Musculo-skeletal(Conventional)
	Musculo-skeletal(Superficial)
	Other (OB/GYN)
	Other (Urology)
Cardiac	Cardiac Adult	N	N	N	N	N	N	N	3,6,7,8
	Cardiac Pediatric	N	N	N	N	N	N	N	3,6,7,8
	Transesophageal
Peripheral Vessel	Peripheral vessel

N = new indication; P = previously cleared by FDA; E = added under this appendix

Note : 1. Combined modes are B/M, B/CFM , B/PD, B/PW or CW, B/Color M, B/BC,B/CFM/PW or CW,B/PD or DPD/PW or CW

2. Small Organ: thyroid, testes, breast

3.3D

4.4D

• 5. Elastography

6. Includes guidance of biopsy (2D)

7. Fusion Harmonic Imaging

8.TDI

Prescription Use メ AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

{28}------------------------------------------------

CBit Series Digital Color Doppler Ultrasound System System: Transducer: D2P64L

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical Application			Mode of Operation
General(Track 1 Only)	Specific(Tracks 1 & 3)	B	M	PWDoppler	CWDoppler	ColorDoppler	PowerDoppler	CombinedModes	Other
Ophthalmic	Ophthalmic
Fetal Imaging &Other	Fetal
	Abdominal	N	N	N	N	N	N	N	3,6,7
	Intra-operative (Specify)
	Intra-operative (Neuro)
	Laparoscopic
	Pediatric
	Small Organ[1] (Specify)
	Neonatal Cephalic	N	N	N	N	N	N	N	3,6,7,8
	Adult Cephalic	N	N	N	N	N	N	N	3,6,7,8
	Trans-rectal
	Trans-vaginal
	Trans-urethral
	Trans-esoph. (non-Card.)
	Musculo-skeletal(Conventional)
	Musculo-skeletal(Superficial)
	Other (OB/GYN)
	Other (Urology)
Cardiac	Cardiac Adult	N	N	N	N	N	N	N	3,6,7,8
	Cardiac Pediatric	N	N	N	N	N	N	N	3,6,7,8
	Transesophageal
Peripheral Vessel	Peripheral vessel

N = new indication; P = previously cleared by FDA; E = added under this appendix

Note : 1. Combined modes are B/M, B/CFM , B/PD, B/PW or CW, B/Color M, B/BC,B/CFM/PW or CW,B/PD or DPD/PW or CW

2. Small Organ: thyroid, testes, breast

3.3D

4.4D

5. Elastography

6. Includes guidance of biopsy (2D)

7. Fusion Harmonic Imaging

8.TDI

Prescription Use × Over-The-Counter Use AND/OR (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

{29}------------------------------------------------

CBit Series Digital Color Doppler Ultrasound System System: Transducer: D5P64L

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical Application			Mode of Operation
General(Track 1 Only)	Specific(Tracks 1 & 3)	B	M	PWDoppler	CWDoppler	ColorDoppler	PowerDoppler	CombinedModes	Other
Ophthalmic	Ophthalmic
Fetal Imaging &Other	Fetal
	Abdominal	N	N	N		N	N	N	3,6,7
	Intra-operative (Specify)
	Intra-operative (Neuro)
	Laparoscopic
	Pediatric	N	N	N		N	N	N	3,6,7,8
	Small Organ[1] (Specify)
	Neonatal Cephalic	N	N	N	N	N	N	N	3,6,7,8
	Adult Cephalic
	Trans-rectal
	Trans-vaginal
	Trans-urethral
	Trans-esoph. (non-Card.)
	Musculo-skeletal(Conventional)
	Musculo-skeletal(Superficial)
	Other (OB/GYN)
	Other (Urology)
Cardiac	Cardiac Adult
	Cardiac Pediatric	N	N	N	N	N	N	N	3,6,7,8
	Transesophageal
Peripheral Vessel	Peripheral vessel

N = new indication; P = previously cleared by FDA; E = added under this appendix

Note : 1. Combined modes are B/M, B/CFM , B/PD, B/PW or CW, B/Color M, B/BC,B/CFM/PW or CW,B/PD or DPD/PW or CW

2. Small Organ: thyroid, testes, breast

3.3D

4.4D

5. Elastography

6. Includes guidance of biopsy (2D)

7. Fusion Harmonic Imaging

8.TDI

Prescription Use × Over-The-Counter Use AND/OR (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

{30}------------------------------------------------

CBit Series Digital Color Doppler Ultrasound System System: Transducer: D2D16L

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical Application			Mode of Operation						Other
General(Track 1 Only)	Specific(Tracks 1 & 3)	B	M	PWDoppler	CWDoppler	ColorDoppler	PowerDoppler	CombinedModes
Ophthalmic	Ophthalmic
Fetal Imaging &Other	Fetal
	Abdominal
	Intra-operative (Specify)
	Intra-operative (Neuro)
	Laparoscopic
	Pediatric
	Small Organ[1] (Specify)
	Neonatal Cephalic
	Adult Cephalic				N
	Trans-rectal
	Trans-vaginal
	Trans-urethral
	Trans-esoph. (non-Card.)
	Musculo-skeletal(Conventional)
	Musculo-skeletal(Superficial)
	Other (OB/GYN)
	Other (Urology)
Cardiac	Cardiac Adult				N
	Cardiac Pediatric				N
	Transesophageal
Peripheral Vessel	Peripheral vessel				N

N = new indication; P = previously cleared by FDA;

E = added under this appendix

Note : 1. Combined modes are B/M, B/CFM , B/PD, B/PW or CW, B/Color M, B/BC,B/CFM/PW or CW,B/PD or DPD/PW or CW

2. Small Organ: thyroid, testes, breast

3.3D

4.4D

5. Elastography

6. Includes guidance of biopsy (2D)

7. Fusion Harmonic Imaging

8.TDI

Prescription Use × AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

{31}------------------------------------------------

CBit Series Digital Color Doppler Ultrasound System System: Transducer: V4C40L

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical Application			Mode of Operation
General(Track 1 Only)	Specific(Tracks 1 & 3)	B	M	PWDoppler	CWDoppler	ColorDoppler	PowerDoppler	CombinedModes	Other
Ophthalmic	Ophthalmic
Fetal Imaging &Other	Fetal	N	N	N	N	N	N	N	3,4,7
	Abdominal	N	N	N	N	N	N	N	3,4,7
	Intra-operative (Specify)
	Intra-operative (Neuro)
	Laparoscopic
	Pediatric
	Small Organ[1] (Specify)
	Neonatal Cephalic
	Adult Cephalic
	Trans-rectal
	Trans-vaginal
	Trans-urethral
	Trans-esoph. (non-Card.)
	Musculo-skeletal(Conventional)
	Musculo-skeletal(Superficial)
	Other (OB/GYN)	N	N	N	N	N	N	N	3,4,7
	Other (Urology)	N	N	N	N	N	N	N	3,4,7
Cardiac	Cardiac Adult
	Cardiac Pediatric
	Transesophageal
Peripheral Vessel	Peripheral vessel

N = new indication; P = previously cleared by FDA; E = added under this appendix

Note : 1. Combined modes are B/M, B/CFM , B/PD, B/PW or CW, B/Color M, B/BC,B/CFM/PW or CW,B/PD or DPD/PW or CW

2. Small Organ: thyroid, testes, breast

3.3D

4.4D

5. Elastography

6. Includes guidance of biopsy (2D)

7. Fusion Harmonic Imaging

8.TDI

Prescription Use × Over-The-Counter Use AND/OR (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

{32}------------------------------------------------

System: CBit Series Digital Color Doppler Ultrasound System Transducer: T5P64L

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical Application		Mode of Operation
General(Track 1 Only)	Specific(Tracks 1 & 3)	B	M	PWDoppler	CWDoppler	ColorDoppler	PowerDoppler	CombinedModes	Other
Ophthalmic	Ophthalmic
Fetal Imaging &Other	Fetal
	Abdominal
	Intra-operative (Specify)
	Intra-operative (Neuro)
	Laparoscopic
	Pediatric
	Small Organ[1] (Specify)
	Neonatal Cephalic
	Adult Cephalic
	Trans-rectal
	Trans-vaginal
	Trans-urethral
	Trans-esoph. (non-Card.)
	Musculo-skeletal(Conventional)
	Musculo-skeletal(Superficial)
	Other (OB/GYN)
	Other (Urology)
Cardiac	Cardiac Adult
	Cardiac Pediatric
	Transesophageal	N	N	N	N	N	N	N	3,7,8
Peripheral Vessel	Peripheral vessel	N	N	N	N	N	N	N	3,7,8

N = new indication; P = previously cleared by FDA; E = added under this appendix

Note : 1. Combined modes are B/M, B/CFM , B/PD, B/PW or CW, B/Color M, B/BC,B/CFM/PW or CW,B/PD or DPD/PW or CW

2. Small Organ: thyroid, testes, breast

3.3D

4.4D

5. Elastography

6. Includes guidance of biopsy (2D)

7. Fusion Harmonic Imaging

8.TDI

Prescription Use × AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

{33}------------------------------------------------

CHISON Medical Technologies Co., Ltd. System: CBit Series Digital Color Doppler Ultrasound System Transducer: MT5P48L

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical Application		Mode of Operation
General	Specific	B	M	PWDoppler	CWDoppler	ColorDoppler	PowerDoppler	CombinedModes	Other
(Track 1 Only)	(Tracks 1 & 3)
Ophthalmic	Ophthalmic
Fetal Imaging &Other	Fetal
	Abdominal
	Intra-operative (Specify)
	Intra-operative (Neuro)
	Laparoscopic
	Pediatric
	Small Organ[1] (Specify)
	Neonatal Cephalic
	Adult Cephalic
	Trans-rectal
	Trans-vaginal
	Trans-urethral
	Trans-esoph. (non-Card.)
	Musculo-skeletal(Conventional)
	Musculo-skeletal(Superficial)
	Other (OB/GYN)
	Other (Urology)
Cardiac	Cardiac Adult
Cardiac	Cardiac Pediatric
	Transesophageal	N	N	N	N	N	N	N	3,7,8
Peripheral Vessel	Peripheral vessel

P = previously cleared by FDA; N = new indication;

E = added under this appendix

Note : 1. Combined modes are B/M, B/CFM , B/PD, B/PW or CW, B/Color M, B/BC,B/CFM/PW or CW,B/PD or DPD/PW or CW

2. Small Organ: thyroid, testes, breast

3.3D

4.4D

5. Elastography

6. Includes guidance of biopsy (2D)

7. Fusion Harmonic Imaging

8.TDI

Prescription Use メ AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

{34}------------------------------------------------

510(k) Summary

In accordance with 21 CFR 807.92 the following summary of information is provided:

1. Submitter:

Submitter:	CHISON Medical Technologies Co., Ltd.
Address:	No.228, Changjiang East Road, Block 51 and 53, Phase 5, Shuofang
	Industrial Park, Xinwu District, Wuxi, Jiangsu, China 214142
	No.9, Xinhuihuan Road, Xinwu District, Wuxi, Jiangsu, China 214028
Contact:	Mr. Liu Qifei
Tel:	[phone]
Fax:	[phone]
Date Prepared:	March 29, 2018

2. Device :

Trade Name: CBit Series Digital Color Doppler Ultrasound System

Common Name: Diagnostic Ultrasound System with Transducers

Classification: Regulatory Class: II Review Category: Tier II

Classfication Name	21 CFR Section	Product Code
Ultrasonic pulsed doppler imaging system	892.1550	90-IYN
Ultrasonic pulsed echo imaging system	892.1560	90-IYO
Diagnostic ultrasonic transducer	892.1570	90-ITX

3. Predicate Device(s):

Device	Manufacturer	Model	510(k)Number
1.Main predicate device	CHISON	SonoBook 9	K170374
2.Reference device	CHISON	QBit 9	K150861

4. Device Description:

The CBit Series Digital Color Doppler Ultrasound System is an integrated preprogrammed color doppler ultrasound imaging system, capable of producing high detail resolution intended for clinical diagnostic imaging applications.

This system is a Track 3 device that employs a wide array of probes that include linear array, convex array and phased array . This system consists of a mobile console with keyboard control panel, power supply module, color LCD monitor and optional probes.

This system is a mobile, general purpose, software controlled, color diagnostic ultrasound system. Its basic function is to acquire ultrasound echo data and to display the image B-Mode (including Fusion Harmonic Imaging). M-Mode, Pulsed (PW) Doppler Mode, Continuous (CW) Doppler Mode, Color Doppler Mode, Power Doppler Mode,

{35}------------------------------------------------

Directional Power Doppler Mode, TDI Mode or a combination of these modes, Elastography, 3D/4D.

5. Indications for Use:

The device is a general-purpose ultrasonic imaging instrument intended for use by a qualified clinician for evaluation of Fetal , Abdominal, Pediatric, Small Organ (breast, thyroid, testes), Neonatal Cephalic ,Adult Cephalic, Cardiac (adult , pediatric), Musculo -skeletal (Conventional, Superficial),Peripheral Vascular, Trans-esophageal, Trans-rectal,Trans-vaginal, OB/GYN and Urology.

6. Summary of Non-Clinical Tests:

The CBit Series Digital Color Doppler Ultrasound System has been evaluated for electrical, mechanical, thermal and electromagnetic compatibility safety, biocompatibility and acoustic output.

The device has been found to conform to applicable medical device safety standards in regards to thermal, mechanical and electrical safety as well as biocompatibility.

IEC 60601-1: 2005 Medical Electrical Equipment - Part 1: General Requirements for Safetv

IEC 60601-1-2: 2014 Medical Electrical Equipment - Part 1-2: General Requirements for Safety - Collateral Standard: Electromagnetic Compatibility -- Requirements and Tests.

IEC 60601-2-37: 2007 Medical electrical equipment - Part 2-37: Particular requirements for the basic safety and essential performance of ultrasonic medical diagnostic and monitoring equipment.

NEMA UD 2:2004, Acoustic Output Measurement Standard for Diagnostic Ultrasound Equipment Version 3.

NEMA UD3: 2004 Standards for Real-time Display of Thermal and Mechanical Acoustic Output Indices on Diagnostic Ultrasound Equipment

ISO 10993-1:2009 Biological evaluation of medical devices -- Part 1: Evaluation and testing within a risk management process

7. Clinical Test:

No clinical testing was required.

Software Documentation for a Moderate Level of Concern, per the FDA guidance document, "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices Document issued on May 11, 2005", is also included as part of this submission.

8. Comparison to Predicate Device:

Items	Main predicate device	Reference device	Submission Device	Remark
	SonoBook 9 DiagnosticUltrasound SystemK170374.	QBit 9 DiagnosticUltrasound SystemK150861	CBit Series DigitalColor DopplerUltrasound System
Indications for Use	FetalAbdominal	FetalAbdominal	FetalAbdominal	SEAnalysis 1
	Main predicate device	Reference device	Submission Device
Items	SonoBook 9 DiagnosticUltrasound SystemK170374.	QBit 9 DiagnosticUltrasound SystemK150861	CBit Series DigitalColor DopplerUltrasound System	Remark
	Pediatric	Pediatric	Pediatric
	Small Organ (breast,thyroid ,testes)	Small Organ (breast,thyroid ,testes)	Small Organ (breast,thyroid ,testes)
	Neonatal Cephalic ,Adult	Neonatal	Neonatal
	Cephalic	Cephalic ,Adult	Cephalic ,Adult
	Trans-rectal	Cephalic	Cephalic
	Trans-vaginal	Trans-rectal	Trans-rectal
	Musculo-skeletal( Conventional, Superficial)	Trans-vaginal	Trans-vaginal
	Cardiac(adult ,pediatric)	Musculo-skeletal( Conventional, Superficial)	Musculo-skeletal( Conventional, Superficial)
	Peripheral Vascular	Cardiac(adult ,pediatric)	Cardiac(adult ,pediatric)
	Urology	Peripheral Vascular	Peripheral VascularOB/GYN,Urology
	Trans-esophageal	Urology	Trans-esophageal
		Trans-esophageal
	Autocorrelation for colorprocessing and FFT forpulseand CW Dopplerprocessing.	Autocorrelation forcolor processing andFFT for pulse and CWDoppler processing.	Autocorrelation for colorprocessing and FFT forpulse and CW Dopplerprocessing.
Design	Supporting Linear,Curve,Phase array andVolumeprobes.	Supporting Linear,Curve , Phase arrayand Volume probes .	Supporting Linear,Curve , Phase array andVolume probes .	Same
	Cine play back capabilityImage file archive	Cine play backcapabilityImage file archive	Cine play backcapabilityImage file archive
	TGC 8 slider	TGC 8 slider	TGC 8 slider	Same
	Depth Range: 0 to 30 cm	Depth Range: 0 to 30cm	Depth Range: 0 to 45cm	SEAnalysis 2
	256 shades of gray	256 shades of gray	256 shades of gray	Same
	B Dynamic range control:60-165 dB, 7/step	B Dynamic rangecontrol: 30-180 dB,5/step	B Dynamic rangecontrol: 20-280dB	SEAnalysis 2
	Gain:0-255,1/step	Gain:0-255,1/step	Gain:0-255,1/step	Same
	Focal Number: adjustable	Focal Number:adjustable	Focal Number:adjustable	Same
OperatingControls	Focus position: adjustable	Focus position:adjustable	Focus position:adjustable	Same
	B steer: available on lineartransducers	B steer: available onlinear transducers	B steer: available onlinear transducers	Same
	B Persistence: 7 steps	B Persistence: 7 steps	B Persistence: 7 steps	Same
	ROI size/position:adjustable	ROI size/position:adjustable	ROI size/position:adjustable	Same
	Color Wall Filter settings:4steps	Color Wall Filtersettings:8 steps	Color Wall Filtersettings:8 steps	Same
	Color Baseline: 7 steps	Color Baseline: 16steps	Color Baseline: 16steps	Same
	Main predicate device	Reference device	Submission Device
Items	SonoBook 9 DiagnosticUltrasound System	QBit 9 DiagnosticUltrasound System	CBit Series DigitalColor DopplerUltrasound System	Remark
	K170374.	K150861
	Color Invert: on/off	Color Invert: on/off	Color Invert: on/off	Same
	PW sweeping speed:3steps	PW sweeping speed:6 steps	PW sweeping speed: 6steps	Same
	PW Wall Filter: 4 steps	PW Wall Filter: 7 steps	PW Wall Filter: 7 steps	Same
	PW sample volume:1-8mm (PW only), 8 steps	PW sample volume:0.5-30mm (PW only),13 steps	PW sample volume:0.5-30mm (PW only)	Same
	PW anglecorrection:-80~80degrees,5/step	PW anglecorrection:-89~89degrees, 1/step	PW anglecorrection:-89~89degrees,1/step	Same
	Baseline: 7steps	Baseline: 8steps	Baseline: 8steps	Same
	Cine control: step, playbackward, playcontinuously	Cine control: step, play backward, playcontinuously	Cine control: step, playbackward, playcontinuously	Same
	Doppler Auto Trace	Doppler Auto Trace	Doppler Auto Trace	Same
	Freeze control:Togglingfreeze key	Freeze control:Togglingfreeze key	Freeze control:Togglingfreeze key	Same
	IEC60601-1	IEC60601-1	IEC60601-1
	IEC60601-1-2	IEC60601-1-2	IEC60601-1-2
SafetyCompliance	ISO 10993-1	ISO 10993-1	ISO 10993-1
	ISO 10993-5	ISO 10993-5	ISO 10993-5	Same
	ISO 10993-10	ISO 10993-10	ISO 10993-10
	AIUM/ NEMA UD2	AIUM/ NEMA UD2	AIUM/ NEMA UD2
	AIUM/ NEMA UD3	AIUM/ NEMA UD3	AIUM/ NEMA UD3
OperationMode	B mode	B mode	B mode	Same
	B/M mode	B/M mode	B/M mode	Same
	M mode	M mode	M mode	Same
	Dual mode	Dual mode	Dual mode	Same
	Quad mode	Quad mode	Quad mode	Same
	CFM mode	CFM mode	CFM mode	Same
	CPA mode	PD mode	CPA mode	Same
	DPD mode	DPD mode	DPD mode	Same
	PW mode	PW mode	PW mode	Same
	B/BC mode	B/BC mode	B/BC mode	Same
	2D Steer	2D Steer	2D Steer	Same
	Triplex mode	Triplex	Triplex mode	Same
	Quadplex	Quadplex	Quadplex	Same
	Free Hand 3D	--	HD 3D	Same
	CW mode	CW mode	CW mode	Same
	Free Steering M mode	Free Steering M mode	Free Steering M mode	Same
	HPRF	HPRF	HPRF	Same
	B-Flow	--	S-flow	Same
	AutoTGC	--	Auto TGC	Same
	Stress Echo	--	Stress echo	Same
	Strain	--	Strain	Same
Items	Main predicate device	Reference device	Submission Device	Remark
	SonoBook 9 DiagnosticUltrasound SystemK170374.	QBit 9 DiagnosticUltrasound SystemK150861	CBit Series DigitalColor DopplerUltrasound System
	TDI	TDI	TDI	Same
	Color M mode	Color M mode	Color M mode	Same
	Curved Panoramic	Curved Panoramic	Curved Panoramic	Same
	Trapezoidal mode	Trapezoidal image	Trapezoidal image	Same
	Compound	compound	compound	Same
	SRA	SRA	SRA	Same
	Chroma	Chroma	Chroma	Same
	Elastography	Elastography	Elastography	Same
	ECG	ECG	ECG	Same
	--	--	LV tracking	SEAnalysis 3
	--	--	LGC	SEAnalysis 4
	Auto IMT	Auto IMT	Auto IMT	Same
	Auto NT	---	Free NT	Same
	Super Needle	Super Needle	Super Needle	Same
	General measurementpackage	general measurementpackage	general measurementpackage	Same
	OB measurement package	OB measurementpackage	OB measurementpackage	Same
	GYN measurementpackage	GYN measurementpackage	GYN measurementpackage	Same
	URO measurementpackage	URO measurementpackage	URO measurementpackage	Same
	Cardiac measurementpackage	cardiac measurementpackage	cardiac measurementpackage	Same
	Vascular measurementpackage	vascular measurementpackage	vascular measurementpackage	Same
	Small parts measurementpackage	small parts measurementpackage	small parts measurementpackage	Same
	Pediatric measurementpackage	Pediatric measurementpackage	Pediatric measurementpackage	Same
	TCD measurementpackage	--	TCD measurementpackage	Same
	4D software package	4D software package	4D software package	Same
	--	--	Breast measurementpackage	SEAnalysis 5
	Virtual HD	Virtual HD	Virtual HD	Same
	X-Contrast	X-Contrast	X-Contrast	Same
	FHI	FHI	FHI	Same
	Q-Image	Q-image	Q-image	Same
	Q-flow	Q-flow	Q-flow	Same
	Q-beam	Q-beam	Q-beam	Same
	AIO	AIO	AIO	Same
	Main predicate device	Reference device	Submission Device
Items	SonoBook 9 DiagnosticUltrasoundSystemK170374.	QBit 9 DiagnosticUltrasound SystemK150861	CBit SeriesDigitalColorDopplerUltrasound System	Remark
DisplayAnnotations	Logo;HospitalName;Exam date;Examtime;AcousticPower;Mechanicalindex;Tissuethermalname,Firstindes;ID,LastName,Middleinitial, Gender, Age; Probemodel;ECGico;Operator;TGCCorve;Focusposition;Thumbnail;Imaginparameters;DynamicTrackball indices	Logo;HospitalName;Examdate;Examtime;Acoustic;MechanicalPowerindex;Thermalindes;Probemodel;ECG ico;TGCCorve;Focusposition;Imagingparameters;DynamicTrackballindices;Systemstatus;Gray/Color bar	Logo;HospitalName;Exam date;Examtime;AcousticPower;Mechanicalindex;Thermalindes; Probeico;TGCmodel; ECGCorve;Focusposition;Imagingparameters;Dynamicindices;TrackballSystemstatus;Gray/Color bar	Same
Measurements	2D mode:DepthDistance ,Area: Ellipse,Trace, SplineTrace, Trace,Length , Volume :Distance,Ellipse, Ellipse + Distance,Distance Ratio ,AreaRatio , IMT, Volume Flow,M mode: Distance,Time,Heart Rate,Velocity;Doppler mode:DVelocity , Time , HeartRate,Acceleration ,DTrace,PS/ED , VolumeFlow;	2D mode: DepthDistance ,Area:Ellipse, Trace, Spline,Cross,Trace Length ,Double DistanceParallel ,Volume :Distance, Ellipse, Ellipse +Distance,LengthRatio ,Area RatioIMT, B Histogram , BProfile, Volume Flow,Color Velocity;M mode:Distance,Time, Slope,Heart Rate,Velocity;Doppler mode: DVelocity ,Time ,HeartRate,Acceleration ,DTrace,PS/ED , VolumeFlow;	2D mode: DepthDistance ,Area: Ellipse,Trace, Spline, TraceLength , DoubleDistanceParallel ,Volume :Distance, Ellipse, Ellipse +Distance, DistanceRatio ,Area Ratio , IMT,Volume Flow, ColorVelocity;M mode:Distance,Time, Slope,Heart Rate,Velocity;Doppler mode:DVelocity ,Time ,HeartRate,Acceleration ,DTrace,PS/ED , VolumeFlow;	Same
TransducerTypes&Connectors	Convex Array,PhasedArray,LinearArray,Volume probe1 ports	Convex Array,Phased Array, LinearArray,Volume probe4ports	Convex Array, PhasedArray, LinearArray,Volume probe4ports	Same
Users / Sites	Hospitals, clinics usage	Hospitals,clinicsusage	Hospitals, clinics usage	Same
AcousticOutput	Track 3; MI, TIS, TIC, TIBDerated Ispta:720mW/cm2 maximum,TIS/TIB/TIC:0.1-4.0Range, Mechanical Index:1.9 Maximum, or DeratedIsppa: 190 W/cm2 max	Track 3; MI, TIS, TIC,TIBDerated Ispta:720mW/cm² maximum,TIS/TIB/TIC:0.1-4.0Range, MechanicalIndex: 1.9 Maximum,	Track 3;MI, TIS, TIC,TIBDerated Ispta:720mW/cm² maximum,TIS/TIB/TIC:0.1-4.0Range, MechanicalIndex: 1.9 Maximum, orDerated Isppa:190	Same
Items	Main predicate device	Reference device	Submission Device	Remark
	SonoBook 9 DiagnosticUltrasound SystemK170374.	QBit 9 DiagnosticUltrasound SystemK150861or Derated Isppa: 190 W/cm² max	CBit Series DigitalColor DopplerUltrasound SystemW/cm² max
PowerRequirements	Power requirements:AC :100V- 240V,Frequenzy:50-60HzOperatingtemperature:10-40 °C ;relative humidity 30-75%;Barometric pressure:700to 1060 hPa	Power requirements:AC :100V- 240V,Frequenzy:50-60HzOperatingtemperature:10-40 °C ;relative humidity 30-75%;Barometric pressure:700 to 1060 hPa	Power requirements:AC :100V- 240V,Frequenzy:50-60HzOperatingtemperature:10-40 °C ;relative humidity 30-75%;Barometric pressure:700 to 1060 hPa	Same

Table 1 Substantial Equivalence Comparison

{36}------------------------------------------------

{37}------------------------------------------------

{38}------------------------------------------------

{39}------------------------------------------------

{40}------------------------------------------------

Comparison Analysis

SE Analysis 1:

Indication for use, compared with the predicate device, the subject device has some differences in presenting OB/GYN.

OB/GYN is short for obstetrics/gynecology. Both predicate and subject device contain OB measurement package and GYN measurement package. OB/GYN application can be seen as part of Fetal, Abdominal and Trans-vaginal applications in some degree. Both of the predicate and subject device comply with the requirements of IEC60601-1 & IEC60601-2-37 and meet clinical requirements. Therefore they can be considered Substantially Equivalent in safety and effectiveness, and no new risk is raised, so the SE is not affected.

SE Analvsis 2:

Operation mode, compared with the predicate device, the subject device employs the same operation controls design and has some differences in value range. But both of them comply with the requirements of IEC60601-1 & IEC60601-2-37 and meet clinical requirements. Therefore they can be considered Substantially Equivalent in safety and effectiveness, and no new risk is raised, so the SE is not affected.

SE Analysis 3:

Operation mode, compared with the predicate device, the subject device employs the same operation controls design and has some differences in presenting LV tracking. LV tracking is a non-invasive method for the assessment of left ventricular(LV) function. The relevant measurement items are IVSd, LVPWd, IVSs, LVIDs, LVPWs, LVLd, LVLs, LVAMd, LVAMs, LVAPs, EDV and ESV, of which are all under cardiac measurement 510(k) Summary Page 7 of 8

{41}------------------------------------------------

package. Both predicate and submission device contain cardiac measurement package. Both of the predicate and subject device comply with the requirements of IEC60601-1 & IEC60601-2-37 and meet clinical requirements. Therefore they can be considered Substantially Equivalent in safety and effectiveness, and no new risk is raised, so the SE is not affected.

SE Analysis 4:

Operation mode, compared with the predicate device, the subject device employs the same operation controls design and has some differences in presenting LGC. LGC (Lateral Gain Compensation) consists of the same tabular array as TGC, which is contained in predicate and submission device. The only difference is that the array is arranged horizontally by LGC while vertically by TGC. The goal of LGC is to have control over the image brightness from side to side.

Both of the predicate and subject device comply with the requirements of IEC60601-1 & IEC60601-2-37 and meet clinical requirements. Therefore they can be considered Substantially Equivalent in safety and effectiveness, and no new risk is raised, so the SE is not affected.

SE Analysis 5:

Operation Controls, compared with the predicate device, the subject device employs the same operation controls design and has some differences in presenting Breast measurement package. Breast measurement is under the small parts measurement package in B mode, including length, height, width and volume measurement items. Both predicate and submission device contain small parts (breast, thyroid, testes) measurement package.

Both of the predicate and subject device comply with the requirements of IEC60601-1 & IEC60601-2-37 and meet clinical requirements. Therefore they can be considered Substantially Equivalent in safety and effectiveness, and no new risk is raised, so the SE is not affected.

9. Substantially Equivalent Conclusion:

In accordance with the Act. 21 CFR Part 807 and based on the information provided in this premarket notification, CHISON Medical Technologies Co., Ltd. concludes that the CBit Series Digital Color Doppler Ultrasound System is substantially equivalent to the predicate devices with regard to safety and effectiveness.

Regulation Number and Section

N/A